fogi70
๐ƒ๐ž๐ž๐ฉ ๐ข๐ง ๐„๐š๐ซ๐ง๐ข๐ง๐ ๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ! There is so much happening this week, that I have to write 2 separate posts to mention all the important ones! Here is the link for the other post: etoro.tw/46e9JcK Let me know in the comments which one you are excited about, and don't forget to hit like! ๐™’๐™š๐™™๐™ฃ๐™š๐™จ๐™™๐™–๐™ฎ $T (AT&T Inc) - According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $0.58. The reported EPS for the same quarter last year was $0.63. The share price rose significantly in the last 6 months, and while I still see it will climb back to its former glory, and despite its healthy dividend, I am looking to sell AT&T as soon as possible. $IBM (International Business Machines Corporation (IBM)) - Has been mostly flat in the past 6 months, and Analysts give it a Hold rating. I would not expect anything groundbreaking from these earnings. How do you think their AI play is working out? ๐™๐™๐™ช๐™ง๐™จ๐™™๐™–๐™ฎ $ABBV (AbbVie Inc) - AbbVie (ABBV) is expected to deliver a year-over-year decline of -4.5% in earnings on higher revenues when it reports results for the quarter ended June 2024. How do you see Pharma? Growing? $RTX (Raytheon-Technologies) - Weapon manufacturers (apologies, Defence stocks) did very well due to geopolitical uncertainties in the past year. Is it still not too late to buy? ๐™๐™ง๐™ž๐™™๐™–๐™ฎ $BMY (Bristol-Myers Squibb Co) - Another Big Pharma to report. Based on 11 analysts' forecasts, the consensus EPS forecast for the quarter is $1.64. The reported EPS for the same quarter last year was $1.75. I've been looking at Bristol for a while, if it drops a bit more, I am inclined to buy in! What do you think? ๐…๐จ๐ฅ๐ฅ๐จ๐ฐ ๐—ฎ๐—ป๐—ฑ ๐—–๐—ผ๐—ฝ๐˜† ๐Ÿ๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ฉ๐จ๐ฌ๐ญ๐ฌ ๐ฅ๐ข๐ค๐ž ๐ญ๐ก๐ข๐ฌ!๐Ÿค‘ Gabor Fogarasi @fogi70 eToro Popular Investor๐Ÿฆ